Potential antiatherosclerotic agents. 5. An acyl-CoA:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity.
D000818:Animals; D000924:Anticholesteremic Agents / Q000138:chemical synthesis*; D001161:Arteriosclerosis / Q000188:drug therapy*; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000201:enzymology; D010671:Phenylurea Compounds / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors*
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D010671:Phenylurea Compounds; C050492:CL 277082; D002784:Cholesterol; D002785:Sterol O-Acyltransferase